SCHEMBL1021920

SCHEMBL1021920

CCCCCCCCCCCCc1ccc(Br)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.63
ADRA2A P08913 2/20 0.63
ADORA3 P0DMS8 2/20 0.63
TACR2 P21452 2/20 0.63
SLC6A2 P23975 2/20 0.63
SLC6A4 P31645 2/20 0.63
SLC6A3 Q01959 2/20 0.63
LMNA P02545 2/20 0.63
ALDH1A1 P00352 2/20 0.63
HSD17B10 Q99714 2/20 0.63
KDM4E B2RXH2 1/20 0.63
SHBG P04278 1/20 0.63
TP53 P04637 1/20 0.63
CYP3A4 P08684 1/20 0.63
HSPD1 P10809 1/20 0.63
ADRB3 P13945 1/20 0.63
HTR2C P28335 1/20 0.63
HSPE1 P61604 1/20 0.63
HIF1A Q16665 1/20 0.63
TST Q16762 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3178688 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL15200865 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL2831631 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL340275 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL4191545 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL349345 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL7471227 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL7781659 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL15353198 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL17857869 0.98 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110452462-A Reinforced flame-retardant polypropylene composite material and preparation method thereof SHANDONG SHOUGUANG JIANYUANCHUN CHEMICAL CO LTD 2019-11-15 CN claimed
US-12466845-B2 Method for producing triorganosilane compound NISSAN CHEMICAL CORPORATION (JP) 2025-11-11 US disclosed
CN-119907823-A Polymer, film, composition, ink, electronic component, photoelectric conversion element, solar cell module, and image sensor 住友化学株式会社 2025-04-29 CN disclosed
CN-113727959-B Method for producing triorganosilane compound 日产化学株式会社 2024-10-25 CN disclosed
EP-3523836-B1 ORGANIC SEMICONDUCTING COMPOUNDS RAYNERGY TEK INC (TW) 2024-09-11 EP disclosed
CN-118546174-A Synthesis method and application of novel hydrolysis-resistant phosphorus antioxidant 南雄志一精细化工有限公司 2024-08-27 CN disclosed
EP-3960725-B1 METHOD FOR PRODUCING TRIORGANOSILANE COMPOUND NISSAN CHEMICAL CORP (JP) 2024-07-10 EP disclosed
CN-118076663-A Composition and ink composition 住友化学株式会社 2024-05-24 CN disclosed
WO-2024075536-A1 POLYMER, FILM, COMPOSITION, INK, ELECTRONIC ELEMENT, PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL MODULE, AND IMAGE SENSOR 住友化学株式会社 2024-04-11 WO disclosed
EP-3751631-B1 POLYMER MATERIAL, MATERIAL FOR ELECTROLUMINESCENCE DEVICE, LIQUID COMPOSITION, THIN FILM, AND ELECTROLUMINESCENCE DEVICE SAMSUNG ELECTRONICS CO LTD (KR) 2023-12-13 EP disclosed
EP-1753747-A1 5,6-DIPHENYL-1,2,4-TRIAZINIC DIMERIC DERIVATIVES AND THE USE THEREOF IN THE FORM OF SUN-PROTECTIVE AGENTS Pierre Fabre Dermo-Cosmetique (FR) 2007-02-21 EP disclosed
US-7122711-B2 Method for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-10-17 US disclosed
WO-2005121128-A1 5,6-DIPHENYL-1,2,4-TRIAZINIC DIMERIC DERIVATIVES AND THE USE THEREOF IN THE FORM OF SUN-PROTECTIVE AGENTS PIERRE FABRE DERMO-COSMETIQUE (FR) 2005-12-22 WO disclosed
US-20040197829-A1 Reaction and separation methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-10-07 US disclosed
US-6749756-B1 Reaction and separation methods UNIVERSITY OF PITTSBURGH 2004-06-15 US disclosed
US-20030158419-A1 Method for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2003-08-21 US disclosed
EP-1312605-A1 Method for producing biaryl compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-05-21 EP disclosed
EP-1269170-A1 REACTION AND SEPARATION METHODS UNIVERSITY OF PITTSBURGH (US) 2003-01-02 EP disclosed
WO-2001061332-A1 REACTION AND SEPARATION METHODS UNIVERSITY OF PITTSBURGH (US) 2001-08-23 WO disclosed
US-6235871-B1 Synthesis of oligoarylamines, and uses and reagents related thereto MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2001-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12466845-B2 Method for producing triorganosilane compound F3, TPI1, DNMT3L ESR1 588/4885ADRA2A 4115/4885ADORA3 569/4885
US-20030158419-A1 Method for producing biaryl compound B2M, BMI1, CYP2W1 ESR1 1343/4885ADRA2A 1855/4885ADORA3 1802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.